Assessment of Treatment in the Clinic

  • R. H. Thomlinson
Part of the Developments in Oncology book series (DION, volume 51)


All concerned with cancer of the breast are anxious for improvements in its treatment. In the absence of some dramatic and unforeseeable advance, the impact of which would be obvious, we must also be concerned with methods of demonstrating and measuring lesser steps that may be in the right direction.


Cytotoxic Agent Cytotoxic Drug Treatment Figure Ethinyl Estradiol Primary Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Collins, V.P., Loeffler, R.K. and Tivey, H. (1956) Observations on growth rates of human tumors. Am. J. Roentgenol. 76:988–1000.Google Scholar
  2. 2.
    Goldie, J.H., Coldman, A.J. and Gudauskas, G.A. (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat. Rep. 66:439–449.Google Scholar
  3. 3.
    Hayward, J.L. et al. (1977) Assessment of response to therapy in advanced breast cancer. Cancer 39:1289–1293.PubMedCrossRefGoogle Scholar
  4. 4.
    Thomlinson, R.H. (1982) Measurement and management of carcinoma of the breast. Clinical Radiology 33:481–493.PubMedCrossRefGoogle Scholar
  5. 5.
    Thomlinson, R.H., Johnson, A.E. and Cheung, C.W.D. (in preparation) Carcinoma of the breast: measurement and management of treatment. 1. The value of the data. 2. The regression of tumors.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • R. H. Thomlinson

There are no affiliations available

Personalised recommendations